Meningococcal Group A vaccine Polysaccharide Dry

Meningococcal group A dry polysaccharide vaccine is intended for the prevention of diseases caused by meningococcal serogroup A.

The vaccine is produced by Microgen NPO (Russia) and is available in powder form for the preparation of an injection solution in a dosage of 250 mcg.

The mechanism of action of the vaccine is based on the formation of specific immunity due to the induction of the production of protective antibodies against the capsular polysaccharide of group A meningococcus.

The vaccine is administered once intramuscularly or subcutaneously. Vaccination is carried out for the purpose of emergency prevention in foci of meningococcal infection, as well as routine immunization of children and adults.